文献速递糖尿病肥胖与代谢综合征

超越传统血糖指标:CGM血糖谱揭示非糖尿病人群心血管代谢风险关联

Beyond Traditional Glycemic Measures: CGM Glycemic Profiles Reveal Associations With Cardiometabolic Risk in Individuals Without Diabetes.
PubMed 文献 · Diabetes Care · 2026-01-01

在Framingham心脏研究1356名无糖尿病或心血管疾病的参与者中,佩戴盲法Dexcom G6 Pro CGM最多10天。CGM指标与10年CVD风险估计及心血管代谢危险因素正相关,即使调整FPG后仍显著;CGM血糖谱与传统血糖状态存在不一致,高血糖谱与更高CVD风险相关。

要点

  • CGM指标与10年CVD风险及高血压、血脂异常正相关,独立于FPG。
  • CGM血糖谱与传统FPG/HbA1c定义的状态存在不一致。
  • 传统糖尿病前期者中部分被CGM归为更高血糖异常谱,伴更高CVD风险。

核心结论

  • 反映连续血糖动态的CGM指标可能提供超越传统血糖指标的心血管代谢风险信息。

研究设计与样本

  • 横断面研究,纳入Framingham心脏研究1356名无糖尿病或CVD的参与者,佩戴盲法Dexcom G6 Pro CGM最多10天。
  • 采用二分类血糖负荷与变异性及CGM指标无监督聚类刻画血糖谱,用多变量调整线性与逻辑回归分析关联。

主要发现

  • CGM指标与10年CVD风险估计及心血管代谢危险因素正相关。
  • 1 SD更高的% time >140 mg/dL(15.4%)与10年CVD风险估计高2%及高血压、血脂异常 odds 高21-26%相关,即使调整FPG后。
  • 传统定义糖尿病前期者中48.1-84.2%被归入更高血糖异常CGM谱,该谱与10年CVD风险估计高6-7%及更差心血管代谢危险因素相关。

关键数值与推荐

  • 1 SD更高的% time >140 mg/dL(15.4%)对应10年CVD风险估计高2%,高血压和血脂异常 odds 高21-26%。
  • 更高血糖异常CGM谱对应10年CVD风险估计高6-7%。

临床怎么用

  • 在无糖尿病人群中,可考虑CGM指标辅助识别传统FPG/HbA1c未捕获的心血管代谢高风险个体。

局限性

  • 横断面设计无法推断因果。
  • 样本以非西班牙裔白人为主(92.6%),外推性受限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Fasting plasma glucose (FPG) and hemoglobin A1c (HbA1c) may not fully capture the heterogeneity underlying dysglycemia or its associations with cardiometabolic risk factors (CMRFs). We cross-sectionally investigated whether continuous glucose monitoring (CGM) measures and glycemic profiles could reveal 10-year cardiovascular disease (CVD) risk and individual CMRFs among individuals without diabetes. RESEARCH DESIGN AND METHODS: We included 1,356 participants without prevalent diabetes or CVD from the Framingham Heart Study, who wore a blinded Dexcom G6 Pro CGM for up to 10 days. CGM glycemic profiles were characterized using 1) binary classification of glycemic burden and variability and 2) unsupervised clustering of CGM measures. We performed multivariable-adjusted linear and logistic regression models to examine associations of CGM measures and profiles with 10-year CVD risk estimates (PREVENT equations) and individual CMRFs. RESULTS: Participants' mean was age 59.3 years; 55.8% were women, and 92.6% were non-Hispanic White. CGM measures were positively associated with 10-year CVD risk estimates and CMRFs. For example, 1 SD higher % time >140 mg/dL (15.4%) was associated with 2% higher 10-year CVD risk estimates and 21-26% higher odds of hypertension and dyslipidemia, even after adjusting for FPG. Glycemic profiles representing higher CGM dysglycemia revealed discordance with traditionally defined glycemic status (FPG and HbA1c). Although 48.1-84.2% of individuals with traditionally defined prediabetes were included in CGM profiles representing higher dysglycemia, such profiles were associated with 6-7% higher 10-year CVD risk estimates, in addition to worse CMRFs. CONCLUSIONS: Glycemic measures reflective of continuous glucose dynamics may provide additional insights into cardiometabolic risk beyond traditional measures.

来源:Diabetes Care,查看原文。版权归原作者所有。

引用

  1. Bakhshi B, Lin H, Sultana N, et al. Beyond Traditional Glycemic Measures: CGM Glycemic Profiles Reveal Associations With Cardiometabolic Risk in Individuals Without Diabetes. Diabetes Care. 2026. PMID: 42752803. doi:10.2337/dc26-1197

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。